Screening embryos isn't doing everything you can — it's moral coercion
Genetic screening can lower disease risk, but its statistical significance is often overstated and it may worsen social inequality. Parents should aim for "good enough" rather than "optimal," and stay wary of commercial companies' moral coercion.
The video won't play here. Listen to the audio instead:
The argument · tap a timestamp to hear it
"Doing everything you can" isn't care — it's moral coercion
The phrase in the listener letter — "shouldn't I do everything I can?" — touched the moral-optimization trap Siegel herself once fell into. She points out that this mindset loads parents with guilt and shame, especially when they face social scrutiny before a child is even born, as if they were already "bad parents." This sets the emotional tone for the discussion that follows.
— Sigal SamuelPolygenic screening measures correlation, not causation
Distinguish PGT-A from polygenic testing: the former is simple and long-established, screening for Down syndrome and sex; the latter is complex, involving traits influenced by thousands of genes, such as depression and IQ. Polygenic testing rests on correlation rather than causation, gene-environment interactions are unknown, and many researchers believe its predictive power is overstated.
— Sigal Samuel"12% lower risk" doesn't mean you won't get the disease
"12% lower risk" sounds appealing, but disease is a continuous spectrum, not an on-off switch. Lowering risk may only delay onset or reduce severity rather than eliminate it. For example, lower diabetes risk might mean shifting from diabetes to prediabetes, or onset a few years later. Consumers easily misread it as a "health guarantee."
— Sigal SamuelScreen out the anxiety gene and creativity may go with it
Traits like anxiety and obsessive-compulsiveness can bring suffering, but they are also linked to creativity and focus. Both Siegel and Noam say that even with a magic wand, they wouldn't want to eliminate these traits in themselves. So screening out "mental illness" genes may simultaneously forfeit potential advantages, which makes the decision more complicated.
— Sigal SamuelOne gene does more than one job — screen one spot, move the whole set
The case for screening faces a scientific challenge: pleiotropy means one gene affects multiple traits, and our understanding of it is limited. If depression-related genes were widely screened out, other traits could be affected unexpectedly. The population-level consequences are unknown, and this is an important reason to oppose screening.
— Sigal SamuelOnce the price drops, it's the parents who don't screen who get coerced
Polygenic testing is currently expensive — Orchid, for example, charges $2,500 per embryo, so testing 10 embryos costs $25,000. This could lead the wealthy to screen for smarter, healthier offspring, widening class gaps. More worrying still: once the price falls and the practice spreads, parents who don't screen may put their children at a disadvantage, creating implicit coercion.
— Sigal SamuelA selected child may come to feel they are a disappointment
If parents choose sex, a child may grow up to discover they are transgender, and feel that the parents' costly sex selection is a burden — even that they are a "disappointment." This knowledge can bring new psychological weight and add complexity to the parent-child relationship.
— Sigal SamuelThe standard for a good parent is good enough, not optimal
Borrowing Nobel laureate Herbert Simon's concept of "satisficing," Siegel suggests parents choose "good enough" rather than "optimal." For example, preventing fatal Tay-Sachs disease is reasonable, but pursuing "high IQ, blue eyes" is excessive. This offers a practical framework for ethical decisions.
— Sigal SamuelIn their own words · checked verbatim
Don't I have to do everything in my power?
Sigal Samuel4:30
It's not like a bill of perfect health.
Sigal Samuel12:13
I wouldn't just be like, let's wave a magic wand and get rid of it.
Sigal Samuel15:00
They might feel like, I extra feel like a disappointment.
Sigal Samuel20:00
What if you could have stopped it? But chose not to.
Sigal Samuel23:09
Figures
| Cost of polygenic testing | $2,500 per embryo | 18:19 |
Glossary
- PGT-A / preimplantation genetic testing for aneuploidy
- Screens for abnormal chromosome number, such as Down syndrome, and can also identify sex.
- polygenic testing
- Assesses complex traits influenced by multiple genes, such as depression and IQ, but with limited predictive power.
- pleiotropy
- One gene affects multiple traits, so screening may produce unknown knock-on effects.
- satisficing
- A decision strategy of choosing "good enough" rather than "optimal," proposed by Herbert Simon.
How to listen
Prospective parents considering IVF or embryo screening, plus tech workers and policymakers focused on reproductive ethics and the social impact of genetic technology.
Ad segments can be skipped, but the core discussion starts at 4:30, so listening in full is recommended.